195 related articles for article (PubMed ID: 35676563)
1. In vitro activity of amixicile against T. vaginalis from clinical isolates.
Jain E; Zaenker EI; Hoffman PS; Warren CA
Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
[TBL] [Abstract][Full Text] [Related]
2. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
Augostini P; Bradley ELP; Raphael BH; Secor WE
Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
5.
Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
[TBL] [Abstract][Full Text] [Related]
6. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
7. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
8. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
9. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
Crowell AL; Sanders-Lewis KA; Secor WE
Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of Conventional Methods with Molecular Methods in the Diagnosis of Trichomonas vaginalis and Investigation of Metronidazole Resistance].
Özel Y; Çavuş İ; Usta A; Vardar Ünlü G; Özbilgin A; Ünlü M
Mikrobiyol Bul; 2023 Oct; 57(4):625-638. PubMed ID: 37885390
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
Hager WD
Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
[TBL] [Abstract][Full Text] [Related]
12. Effects of SQ109 on Trichomonas vaginalis.
de Souza TG; Granado R; Benaim G; de Souza W; Benchimol M
Exp Parasitol; 2023 Jul; 250():108549. PubMed ID: 37196704
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
14. Secnidazole: a treatment for trichomoniasis in adolescents and adults.
Muzny CA; Van Gerwen OT; Legendre D
Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1067-1076. PubMed ID: 35642509
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
[TBL] [Abstract][Full Text] [Related]
18. Secnidazole for Trichomoniasis in Women and Men.
Muzny CA; Van Gerwen OT
Sex Med Rev; 2022 Apr; 10(2):255-262. PubMed ID: 35153156
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic aspects of trichomoniasis].
Vukićević J; Jankicević J
Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]